Regulation of anxiety by GABAA receptors in the rat amygdala

Pharmacology, Biochemistry, and Behavior
S K Sanders, A Shekhar

Abstract

Blockade of GABAergic inhibition in the region of the anterior basolateral amygdala (BLA) of rats elicits physiologic changes associated with a defense reaction. The present study was undertaken to determine whether GABA receptors in the BLA might be involved in regulating experimental anxiety using the social interaction (SI) and conflict test. Guide cannulae were stereotaxically implanted bilaterally in the BLA of rats for intracerebral microinjections. In the BLA, injection of the GABAA receptor antagonists bicuculline methiodide (BMI) and picrotoxin (PIC) produced anxiogenic-like effects in the SI paradigm, as did BMI injection using the conflict paradigm. Injection of the GABAA agonist muscimol (MUS) into the central nucleus of the amygdala (Ce) produced anxiolytic-like effects in the SI test. Microinjection of MUS, baclofen (GABAB agonist), 2OH-saclofen (GABAB antagonist) or strychnine (glycine antagonist) into the BLA or BMI into the Ce elicited no change in experimental anxiety as measured by the SI test. These results suggest that endogenous GABA acts tonically at GABAA receptors in the BLA to inhibit anxiety responses.

References

Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Aug 13, 1982·European Journal of Pharmacology·J Scheel-Krüger, E N Petersen
Nov 1, 1954·A.M.A. Archives of Neurology and Psychiatry·W FEINDEL, W PENFIELD
Aug 1, 1956·Journal of Comparative and Physiological Psychology·L WEISKRANTZ
Jul 1, 1963·Archives of Neurology·H NARABAYASHIM NAGAHATA

❮ Previous
Next ❯

Citations

Jan 17, 2007·Psychopharmacology·Younglim LeeAnantha Shekhar
Aug 29, 1996·European Journal of Pharmacology·K H HuhR W Olsen
Mar 1, 2005·European Journal of Pharmacology·Donald R GehlertTammy J Sajdyk
Jun 19, 2013·Journal of Chemical Neuroanatomy·Birger V DieriksMaurice A Curtis
May 7, 2013·Neuropharmacology·Lin-Lin BiTian-Ming Gao
Feb 26, 2003·European Journal of Pharmacology·Sandra E File, Pallab Seth
May 24, 2003·Neuropharmacology·A J BoileauR A Pearce
Jan 1, 1996·Neuropharmacology·Z U KhanA L De Blas
Jan 1, 1996·Neuropharmacology·W WisdenS Bahn
Jun 23, 2001·Pharmacology, Biochemistry, and Behavior·M ZarrindastM Sadeghi-Hariri
Feb 7, 2002·Pharmacology, Biochemistry, and Behavior·Thayne L SweetenChristopher J McDougle
Jan 19, 2000·Pharmacology, Biochemistry, and Behavior·E G MoreiraV S Vassilieff
Dec 19, 1998·Psychiatry Research·E P NobleR S Sparkes
Sep 5, 1998·Brain Research. Molecular Brain Research·O F BuenoN J Leidenheimer
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Jul 18, 2002·Brain Research Bulletin·Christie Ramos Andrade Leite-Panissi, Leda Menescal-de-Oliveira
Feb 26, 2004·Behavioral Neuroscience·S B McHughD M Bannerman
Jun 10, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Xiaolong JiangHe Li
Sep 4, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Francine M Benes
Jan 29, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Marvin R DiazBrian A McCool

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.